Latest period
$1.75B
YoY change
+29.2%
5Y CAGR
+19.0%
Peak year (2025)
$1.66B
Latest annual
$1.66B
Free Cash Flow history chart for ResMed (RMD) from 1993 to 2025
Latest: $1.66B
Free Cash Flow growth chart for ResMed (RMD) from 1993 to 2025
Latest: +29.2%
Free Cash Flow history table for ResMed (RMD) from 1993 to 2025
| 2025 | $1.66B | +29.2% | +$375.32M | ||
| 2024 | $1.29B | +130.0% | +$727.11M | ||
| 2023 | $559.30M | +186.7% | +$364.19M | ||
| 2022 | $195.11M | -68.5% | −$424.78M | ||
| 2021 | $619.89M | -11.0% | −$76.42M | ||
| 2020 | $696.32M | +82.4% | +$314.61M | ||
| 2019 | $381.71M | -12.0% | −$51.86M | ||
| 2018 | $433.57M | +26.6% | +$90.99M | ||
| 2017 | $342.58M | -28.6% | −$137.53M | ||
| 2016 | $480.10M | +54.3% | +$168.87M | ||
| 2015 | $311.24M | +0.4% | +$1.12M | ||
| 2014 | $310.11M | -6.3% | −$20.93M | ||
| 2013 | $331.04M | +2.8% | +$8.99M | ||
| 2012 | $322.05M | +54.7% | +$113.86M | ||
| 2011 | $208.19M | +64.5% | +$81.62M | ||
| 2010 | $126.57M | +1.5% | +$1.92M | ||
| 2009 | $124.66M | +100.9% | +$62.60M | ||
| 2008 | $62.06M | +358.0% | +$48.51M | ||
| 2007 | $13.55M | -464.1% | +$17.27M | ||
| 2006 | −$3.72M | -111.9% | −$35.11M | ||
| 2005 | $31.39M | +62.7% | +$12.09M | ||
| 2004 | $19.30M | -42.7% | −$14.35M | ||
| 2003 | $33.65M | +351.4% | +$26.19M | ||
| 2002 | $7.46M | +261.7% | +$5.39M | ||
| 2001 | $2.06M | -49.8% | −$2.05M | ||
| 2000 | $4.11M | -195.5% | +$8.41M | ||
| 1999 | −$4.30M | -14.0% | +$700.00K | ||
| 1998 | −$5.00M | -190.9% | −$10.50M | ||
| 1997 | $5.50M | +175.0% | +$3.50M | ||
| 1996 | $2.00M | -281.8% | +$3.10M | ||
| 1995 | −$1.10M | -184.6% | −$2.40M | ||
| 1994 | $1.30M | +85.7% | +$600.00K | ||
| 1993 | $700.00K | — | — |
- 2025$1.66B+29.2%
- 2024$1.29B+130.0%
- 2023$559.30M+186.7%
- 2022$195.11M-68.5%
- 2021$619.89M-11.0%
- 2020$696.32M+82.4%
- 2019$381.71M-12.0%
- 2018$433.57M+26.6%
- 2017$342.58M-28.6%
- 2016$480.10M+54.3%
- 2015$311.24M+0.4%
- 2014$310.11M-6.3%
- 2013$331.04M+2.8%
- 2012$322.05M+54.7%
- 2011$208.19M+64.5%
- 2010$126.57M+1.5%
- 2009$124.66M+100.9%
- 2008$62.06M+358.0%
- 2007$13.55M-464.1%
- 2006−$3.72M-111.9%
- 2005$31.39M+62.7%
- 2004$19.30M-42.7%
- 2003$33.65M+351.4%
- 2002$7.46M+261.7%
- 2001$2.06M-49.8%
- 2000$4.11M-195.5%
- 1999−$4.30M-14.0%
- 1998−$5.00M-190.9%
- 1997$5.50M+175.0%
- 1996$2.00M-281.8%
- 1995−$1.10M-184.6%
- 1994$1.30M+85.7%
- 1993$700.00K—
Free Cash Flow values are taken from ResMed's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at ResMed (RMD)
Free Cash Flow for ResMed (RMD): headline value $1.75B · YoY +29.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of ResMed (RMD) free cash flow is $1.66B – grew 29.2% year-over-year.
Over 2020–2025 (5 years), ResMed free cash flow expanded at a +19.0% compound annual rate, sustaining 3 straight years of year-over-year growth.
The highest annual free cash flow of $1.66B was reported in 2025. The lowest in the available history was −$5.00M in 1998.
ResMed Free Cash Flow by Year
ResMed Free Cash Flow 2025: $1.66B
ResMed free cash flow in 2025 was $1.66B, grew 29.2% from 2024. This figure represents the highest annual value in the available history.
ResMed Free Cash Flow 2024: $1.29B
2024's free cash flow for ResMed came in at $1.29B, surged 130.0% from 2023.
ResMed Free Cash Flow 2023: $559.30M
ResMed posted free cash flow of $559.30M in 2023, surged 186.7% from 2022.
ResMed Free Cash Flow 2022: $195.11M
In 2022, ResMed reported free cash flow of $195.11M, plunged 68.5% below 2021.
ResMed Free Cash Flow 2021: $619.89M
ResMed free cash flow in 2021 was $619.89M.
See more financial history for ResMed (RMD).
Sector peers by Free Cash Flow
Healthcare peers of ResMed (RMD), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation